NRAS and Miyoshi myopathy: Although CM is highly associated with UV exposure and BRAF/NRAS mutations, low association to these signatures in MM strongly suggests that MM has distinct mechanisms involved in its initiation and progression, necessitating unique treatment strategies separate from CM treatment based on its molecular profile.